Cargando…

Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories

Current research primarily emphasizes the generalized correlations between airborne pollution and respiratory diseases, seldom considering the differential impacts of particular particulate matter sizes on chronic obstructive pulmonary disease (COPD) exacerbations in distinct Global Initiative for O...

Descripción completa

Detalles Bibliográficos
Autores principales: Bălă, Gabriel-Petrică, Rosca, Ovidiu, Bratosin, Felix, Shetty, Uday Shree Akkala, Vutukuru, Sai Diksha, Sanda, Isabella-Ionela, Marc, Monica, Fira-Mladinescu, Ovidiu, Oancea, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608161/
https://www.ncbi.nlm.nih.gov/pubmed/37888116
http://dx.doi.org/10.3390/jpm13101505
_version_ 1785127715051929600
author Bălă, Gabriel-Petrică
Rosca, Ovidiu
Bratosin, Felix
Shetty, Uday Shree Akkala
Vutukuru, Sai Diksha
Sanda, Isabella-Ionela
Marc, Monica
Fira-Mladinescu, Ovidiu
Oancea, Cristian
author_facet Bălă, Gabriel-Petrică
Rosca, Ovidiu
Bratosin, Felix
Shetty, Uday Shree Akkala
Vutukuru, Sai Diksha
Sanda, Isabella-Ionela
Marc, Monica
Fira-Mladinescu, Ovidiu
Oancea, Cristian
author_sort Bălă, Gabriel-Petrică
collection PubMed
description Current research primarily emphasizes the generalized correlations between airborne pollution and respiratory diseases, seldom considering the differential impacts of particular particulate matter sizes on chronic obstructive pulmonary disease (COPD) exacerbations in distinct Global Initiative for Obstructive Lung Disease (GOLD) categories. This study hypothesizes a critical association between particulate matter sizes (PM 1.0, PM 2.5, and PM 10) and exacerbation frequency in COPD patients categorized under GOLD 3 and GOLD 4, with a potential augmenting role played by proximity to main roads and industrial areas. This research aspires to offer a nuanced perspective on the exacerbation patterns in these groups, setting the stage for targeted intervention strategies. Utilizing a prospective design, this study followed 79 patients divided into GOLD 3 (n = 47) and GOLD 4 (n = 32) categories. The participants were monitored for ten days for daily activity levels, symptoms, living conditions, and airborne particulate matter concentrations, with spirometric evaluations employed to measure lung function. Statistical analyses were used to identify potential risk factors and significant associations. The analysis revealed substantial disparities in airborne particulate matter sizes between the two groups. The mean PM 1.0 concentration was notably higher in GOLD 4 patients (26 µg/m(3)) compared to GOLD 3 patients (18 µg/m(3)). Similarly, elevated PM 2.5 levels were observed in the GOLD 4 category (35 µg/m(3)) in contrast to the GOLD 3 category (24 µg/m(3)). A vital finding was the increased frequency of exacerbations in individuals residing within 200 m of main roads compared to those living further away (OR = 2.5, 95% CI: 1.5–4.1). Additionally, patients residing in homes smaller than 50 square meters demonstrated a greater frequency of exacerbations. Spirometry results corroborated the exacerbated condition in GOLD 4 patients, indicating a significant decline in lung function parameters compared to the GOLD 3 group. This study substantiates a significant association between airborne particulate matter sizes and exacerbation frequencies in COPD patients, particularly accentuating the increased risk in GOLD 4 patients. Our findings underscore the pivotal role of environmental factors, including the size of living areas and proximity to main roads, in influencing COPD exacerbations. These results suggest the need for personalized healthcare strategies and interventions, which account for environmental risk factors and the distinctions between GOLD 3 and GOLD 4 categories of COPD patients.
format Online
Article
Text
id pubmed-10608161
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106081612023-10-28 Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories Bălă, Gabriel-Petrică Rosca, Ovidiu Bratosin, Felix Shetty, Uday Shree Akkala Vutukuru, Sai Diksha Sanda, Isabella-Ionela Marc, Monica Fira-Mladinescu, Ovidiu Oancea, Cristian J Pers Med Article Current research primarily emphasizes the generalized correlations between airborne pollution and respiratory diseases, seldom considering the differential impacts of particular particulate matter sizes on chronic obstructive pulmonary disease (COPD) exacerbations in distinct Global Initiative for Obstructive Lung Disease (GOLD) categories. This study hypothesizes a critical association between particulate matter sizes (PM 1.0, PM 2.5, and PM 10) and exacerbation frequency in COPD patients categorized under GOLD 3 and GOLD 4, with a potential augmenting role played by proximity to main roads and industrial areas. This research aspires to offer a nuanced perspective on the exacerbation patterns in these groups, setting the stage for targeted intervention strategies. Utilizing a prospective design, this study followed 79 patients divided into GOLD 3 (n = 47) and GOLD 4 (n = 32) categories. The participants were monitored for ten days for daily activity levels, symptoms, living conditions, and airborne particulate matter concentrations, with spirometric evaluations employed to measure lung function. Statistical analyses were used to identify potential risk factors and significant associations. The analysis revealed substantial disparities in airborne particulate matter sizes between the two groups. The mean PM 1.0 concentration was notably higher in GOLD 4 patients (26 µg/m(3)) compared to GOLD 3 patients (18 µg/m(3)). Similarly, elevated PM 2.5 levels were observed in the GOLD 4 category (35 µg/m(3)) in contrast to the GOLD 3 category (24 µg/m(3)). A vital finding was the increased frequency of exacerbations in individuals residing within 200 m of main roads compared to those living further away (OR = 2.5, 95% CI: 1.5–4.1). Additionally, patients residing in homes smaller than 50 square meters demonstrated a greater frequency of exacerbations. Spirometry results corroborated the exacerbated condition in GOLD 4 patients, indicating a significant decline in lung function parameters compared to the GOLD 3 group. This study substantiates a significant association between airborne particulate matter sizes and exacerbation frequencies in COPD patients, particularly accentuating the increased risk in GOLD 4 patients. Our findings underscore the pivotal role of environmental factors, including the size of living areas and proximity to main roads, in influencing COPD exacerbations. These results suggest the need for personalized healthcare strategies and interventions, which account for environmental risk factors and the distinctions between GOLD 3 and GOLD 4 categories of COPD patients. MDPI 2023-10-18 /pmc/articles/PMC10608161/ /pubmed/37888116 http://dx.doi.org/10.3390/jpm13101505 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bălă, Gabriel-Petrică
Rosca, Ovidiu
Bratosin, Felix
Shetty, Uday Shree Akkala
Vutukuru, Sai Diksha
Sanda, Isabella-Ionela
Marc, Monica
Fira-Mladinescu, Ovidiu
Oancea, Cristian
Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories
title Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories
title_full Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories
title_fullStr Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories
title_full_unstemmed Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories
title_short Airborne Particulate Matter Size and Chronic Obstructive Pulmonary Disease Exacerbations: A Prospective, Risk-Factor Analysis Comparing Global Initiative for Obstructive Lung Disease 3 and 4 Categories
title_sort airborne particulate matter size and chronic obstructive pulmonary disease exacerbations: a prospective, risk-factor analysis comparing global initiative for obstructive lung disease 3 and 4 categories
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608161/
https://www.ncbi.nlm.nih.gov/pubmed/37888116
http://dx.doi.org/10.3390/jpm13101505
work_keys_str_mv AT balagabrielpetrica airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT roscaovidiu airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT bratosinfelix airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT shettyudayshreeakkala airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT vutukurusaidiksha airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT sandaisabellaionela airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT marcmonica airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT firamladinescuovidiu airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories
AT oanceacristian airborneparticulatemattersizeandchronicobstructivepulmonarydiseaseexacerbationsaprospectiveriskfactoranalysiscomparingglobalinitiativeforobstructivelungdisease3and4categories